{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:20:11Z","timestamp":1788495611442,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2021-QN-A05"],"award-info":[{"award-number":["CY2021-QN-A05"]}]},{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2021-QN-A05"],"award-info":[{"award-number":["CY2021-QN-A05"]}]},{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2021-QN-A05"],"award-info":[{"award-number":["CY2021-QN-A05"]}]},{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2021-QN-A05"],"award-info":[{"award-number":["CY2021-QN-A05"]}]},{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2021-QN-A05"],"award-info":[{"award-number":["CY2021-QN-A05"]}]},{"name":"Lanzhou Science and technology project","award":["2022-ZD-104"],"award-info":[{"award-number":["2022-ZD-104"]}]},{"name":"Lanzhou Science and technology project","award":["2022-ZD-104"],"award-info":[{"award-number":["2022-ZD-104"]}]},{"name":"Science and technology project of Gansu Province","award":["21JR1RA148"],"award-info":[{"award-number":["21JR1RA148"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770525"],"award-info":[{"award-number":["81770525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cuiying Scientific and Technological Key Cultivation Program of Lanzhou University Second Hospital","award":["CY2018-ZD01"],"award-info":[{"award-number":["CY2018-ZD01"]}]},{"name":"Industrial support and guidance project for institutions of higher learning in Gansu province","award":["2019C-21"],"award-info":[{"award-number":["2019C-21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11010-022-04578-y","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T10:02:57Z","timestamp":1665482577000},"page":"1083-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Constructed the ceRNA network and predicted a FEZF1-AS1\/miR-92b-3p\/ZIC5 axis in colon cancer"],"prefix":"10.1007","volume":"478","author":[{"given":"Xiaoping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingfan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueni","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1392-7927","authenticated-orcid":false,"given":"Dekui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"key":"4578_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"4578_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145\u2013164","journal-title":"CA Cancer J Clin"},{"key":"4578_CR3","doi-asserted-by":"publisher","first-page":"6974","DOI":"10.1038\/s41598-020-63827-6","volume":"10","author":"J Pan","year":"2020","unstructured":"Pan J, Cen L, Xu L et al (2020) Prevalence and risk factors for colorectal polyps in a Chinese population: a retrospective study. Sci Rep 10:6974","journal-title":"Sci Rep"},{"key":"4578_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-020-01201-w","volume":"19","author":"H Wu","year":"2020","unstructured":"Wu H, Qin W, Lu S et al (2020) Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2\u2019-O-methylation via NOP58 recruitment in colorectal cancer. Mol Cancer 19:95","journal-title":"Mol Cancer"},{"key":"4578_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/cancers12071881","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Wang L, Xie Z et al (2020) Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer. Cancers (Basel). 12:1881","journal-title":"Cancers (Basel)."},{"key":"4578_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/pharmaceutics13030424","volume":"13","author":"M Georgieva","year":"2021","unstructured":"Georgieva M, Gospodinova Z, Keremidarska-Markova M et al (2021) PEGylated nanographene oxide in combination with near-infrared laser irradiation as a smart nanocarrier in colon cancer targeted therapy. Pharmaceutics. 13:424","journal-title":"Pharmaceutics."},{"key":"4578_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/10717544.2021.1914777","volume":"28","author":"W Du","year":"2021","unstructured":"Du W, Yang X, He S et al (2021) Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer. Drug Deliv 28:920\u2013929","journal-title":"Drug Deliv"},{"key":"4578_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41590-020-00848-3","volume":"22","author":"N Lopes","year":"2021","unstructured":"Lopes N, McIntyre C, Martin S et al (2021) Distinct metabolic programs established in the thymus control effector functions of \u03b3\u03b4 T cell subsets in tumor microenvironments. Nat Immunol 22:179\u2013192","journal-title":"Nat Immunol"},{"key":"4578_CR9","doi-asserted-by":"publisher","first-page":"120654","DOI":"10.1016\/j.biomaterials.2021.120654","volume":"269","author":"X Wu","year":"2021","unstructured":"Wu X, Yang H, Chen X et al (2021) Nano-herb medicine and PDT induced synergistic immunotherapy for colon cancer treatment. Biomaterials 269:120654","journal-title":"Biomaterials"},{"key":"4578_CR10","doi-asserted-by":"publisher","first-page":"e2100712","DOI":"10.1002\/advs.202100712","volume":"8","author":"D Ding","year":"2021","unstructured":"Ding D, Zhong H, Liang R et al (2021) Multifunctional nanodrug mediates synergistic photodynamic therapy and MDSCs-targeting immunotherapy of colon cancer. Adv Sci (Weinh) 8:e2100712","journal-title":"Adv Sci (Weinh)"},{"key":"4578_CR11","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/ijms20122919","volume":"20","author":"X Zhang","year":"2019","unstructured":"Zhang X, Zhang H, Shen B, Sun XF (2019) Chromogranin-A expression as a novel biomarker for early diagnosis of colon cancer patients. Int J Mol Sci. 20:2919","journal-title":"Int J Mol Sci."},{"key":"4578_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrc1739","volume":"5","author":"JA Ludwig","year":"2005","unstructured":"Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5:845\u2013856","journal-title":"Nat Rev Cancer"},{"key":"4578_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.trsl.2016.10.001","volume":"181","author":"M Weng","year":"2017","unstructured":"Weng M, Wu D, Yang C et al (2017) Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer. Transl Res 181:108\u2013120","journal-title":"Transl Res"},{"key":"4578_CR14","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1093\/hmg\/ddu309","volume":"23","author":"I Ezkurdia","year":"2014","unstructured":"Ezkurdia I, Juan D, Rodriguez JM et al (2014) Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes. Hum Mol Genet 23:5866\u20135878","journal-title":"Hum Mol Genet"},{"key":"4578_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M (2015) The emerging role of lncRNAs in cancer. Nat Med 21:1253\u20131261","journal-title":"Nat Med"},{"key":"4578_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R et al (2015) The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 47:199\u2013208","journal-title":"Nat Genet"},{"key":"4578_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136:629\u2013641","journal-title":"Cell"},{"key":"4578_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/CBM-160376","volume":"19","author":"L Ning","year":"2017","unstructured":"Ning L, Li Z, Wei D et al (2017) LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma. Cancer Biomark 19:75\u201383","journal-title":"Cancer Biomark"},{"key":"4578_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00432-017-2370-1","volume":"143","author":"JN Xiao","year":"2017","unstructured":"Xiao JN, Yan TH, Yu RM et al (2017) Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. J Cancer Res Clin Oncol 143:981","journal-title":"J Cancer Res Clin Oncol"},{"key":"4578_CR20","doi-asserted-by":"publisher","first-page":"44033","DOI":"10.1038\/srep44033","volume":"7","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wang Y, Chen M et al (2017) CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma. Sci Rep 7:44033","journal-title":"Sci Rep"},{"key":"4578_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2017.02.035","volume":"395","author":"Y Li","year":"2017","unstructured":"Li Y, Wu Z, Yuan J et al (2017) Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. Cancer Lett 395:31\u201344","journal-title":"Cancer Lett"},{"key":"4578_CR22","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1158\/1078-0432.CCR-17-2967","volume":"24","author":"Z Bian","year":"2018","unstructured":"Bian Z, Zhang J, Li M et al (2018) LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling. Clin Cancer Res 24:4808\u20134819","journal-title":"Clin Cancer Res"},{"key":"4578_CR23","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/jcp.25854","volume":"233","author":"P Paul","year":"2018","unstructured":"Paul P, Chakraborty A, Sarkar D et al (2018) Interplay between miRNAs and human diseases. J Cell Physiol 233:2007\u20132018","journal-title":"J Cell Physiol"},{"key":"4578_CR24","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.3390\/ijms20236055","volume":"20","author":"J Konovalova","year":"2019","unstructured":"Konovalova J, Gerasymchuk D, Parkkinen I et al (2019) Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases. Int J Mol Sci. 20:6055","journal-title":"Int J Mol Sci."},{"key":"4578_CR25","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1056\/NEJMp058190","volume":"353","author":"C-Z Chen","year":"2005","unstructured":"Chen C-Z (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353:1768\u20131771","journal-title":"N Engl J Med"},{"key":"4578_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"4578_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-017-0723-7","volume":"16","author":"M Long","year":"2017","unstructured":"Long M, Zhan M, Xu S et al (2017) miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Mol Cancer 16:167","journal-title":"Mol Cancer"},{"key":"4578_CR28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/JCI97225","volume":"128","author":"X Tan","year":"2018","unstructured":"Tan X, Banerjee P, Liu X et al (2018) The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest 128:1267\u20131282","journal-title":"J Clin Invest"},{"key":"4578_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.canlet.2016.09.034","volume":"383","author":"L Chang","year":"2016","unstructured":"Chang L, Yuan Y, Li C et al (2016) Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma. Cancer Lett 383:183\u2013194","journal-title":"Cancer Lett"},{"key":"4578_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10565-019-09506-3","volume":"36","author":"W Zhan","year":"2020","unstructured":"Zhan W, Liao X, Chen Z et al (2020) LINC00858 promotes colorectal cancer by sponging miR-4766-5p to regulate PAK2. Cell Biol Toxicol 36:333\u2013347","journal-title":"Cell Biol Toxicol"},{"key":"4578_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ebiom.2018.12.049","volume":"41","author":"M Zhuang","year":"2019","unstructured":"Zhuang M, Zhao S, Jiang Z et al (2019) MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility. EBioMedicine 41:286\u2013298","journal-title":"EBioMedicine"},{"key":"4578_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-018-0870-5","volume":"17","author":"H Liang","year":"2018","unstructured":"Liang H, Yu T, Han Y et al (2018) LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer 17:119","journal-title":"Mol Cancer"},{"key":"4578_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.canlet.2018.01.036","volume":"418","author":"C Li","year":"2018","unstructured":"Li C, Wan L, Liu Z et al (2018) Long non-coding RNA XIST promotes TGF-\u03b2-induced epithelial-mesenchymal transition by regulating miR-367\/141-ZEB2 axis in non-small-cell lung cancer. Cancer Lett 418:185\u2013195","journal-title":"Cancer Lett"},{"key":"4578_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB et al (2013) The cancer genome atlas pan-cancer analysis project. Nat Genet 45:1113\u20131120","journal-title":"Nat Genet"},{"key":"4578_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/517109a","volume":"517","author":"S Tippmann","year":"2015","unstructured":"Tippmann S (2015) Programming tools: adventures with R. Nature 517:109\u2013110","journal-title":"Nature"},{"key":"4578_CR36","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47","journal-title":"Nucleic Acids Res"},{"key":"4578_CR37","doi-asserted-by":"publisher","first-page":"D189","DOI":"10.1093\/nar\/gkz804","volume":"48","author":"Y Lin","year":"2020","unstructured":"Lin Y, Liu T, Cui T et al (2020) RNAInter in 2020: RNA interactome repository with increased coverage and annotation. Nucleic Acids Res 48:D189\u2013D197","journal-title":"Nucleic Acids Res"},{"key":"4578_CR38","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504","journal-title":"Genome Res"},{"key":"4578_CR39","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"4578_CR40","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4578_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12885-019-5983-8","volume":"19","author":"R-S Zhou","year":"2019","unstructured":"Zhou R-S, Zhang E-X, Sun Q-F et al (2019) Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer 19:779","journal-title":"BMC Cancer"},{"key":"4578_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab286","author":"CC Wang","year":"2021","unstructured":"Wang CC, Han CD, Zhao Q, Chen X (2021) Circular RNAs and complex diseases: from experimental results to computational models. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab286","journal-title":"Brief Bioinform."},{"key":"4578_CR43","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77:3965\u20133981","journal-title":"Cancer Res"},{"key":"4578_CR44","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/ERC-17-0188","volume":"25","author":"AK Murugan","year":"2018","unstructured":"Murugan AK, Munirajan AK, Alzahrani AS (2018) Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocr Relat Cancer 25:R59\u2013R82","journal-title":"Endocr Relat Cancer"},{"key":"4578_CR45","doi-asserted-by":"publisher","first-page":"13726","DOI":"10.18632\/aging.202960","volume":"13","author":"J Yao","year":"2021","unstructured":"Yao J, Yang Z, Yang J et al (2021) Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107\/Wnt\/\u03b2-catenin axis. Aging (Albany NY). 13:13726","journal-title":"Aging (Albany NY)."},{"key":"4578_CR46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41419-020-02877-0","volume":"11","author":"P Dasgupta","year":"2020","unstructured":"Dasgupta P, Kulkarni P, Majid S et al (2020) LncRNA CDKN2B-AS1\/miR-141\/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Cell Death Dis 11:660","journal-title":"Cell Death Dis"},{"key":"4578_CR47","doi-asserted-by":"publisher","first-page":"17167","DOI":"10.18632\/aging.103667","volume":"12","author":"J Fang","year":"2020","unstructured":"Fang J, Ding Z (2020) SNAI1 is a prognostic biomarker and correlated with immune infiltrates in gastrointestinal cancers. Aging (Albany NY) 12:17167\u201317208","journal-title":"Aging (Albany NY)"},{"key":"4578_CR48","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/cas.13419","volume":"108","author":"R Satow","year":"2017","unstructured":"Satow R, Inagaki S, Kato C et al (2017) Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells. Cancer Sci 108:2405\u20132412","journal-title":"Cancer Sci"},{"key":"4578_CR49","doi-asserted-by":"publisher","first-page":"e3183","DOI":"10.1002\/jgm.3183","volume":"22","author":"W Dang","year":"2020","unstructured":"Dang W, Zhu Z (2020) MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma. J Gene Med 22:e3183","journal-title":"J Gene Med"},{"key":"4578_CR50","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.18632\/aging.102979","volume":"12","author":"K Lin","year":"2020","unstructured":"Lin K, Huang J, Luo H et al (2020) Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer. Aging (Albany NY) 12:5832\u20135857","journal-title":"Aging (Albany NY)"},{"key":"4578_CR51","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"The Gene Ontology Consortium","year":"2015","unstructured":"The Gene Ontology Consortium (2015) Gene ontology consortium: going forward. Nucleic Acids Res 43:D1049\u2013D1056","journal-title":"Nucleic Acids Res"},{"key":"4578_CR52","doi-asserted-by":"publisher","first-page":"e0184129","DOI":"10.1371\/journal.pone.0184129","volume":"12","author":"L Chen","year":"2017","unstructured":"Chen L, Zhang YH, Wang S et al (2017) Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS ONE 12:e0184129","journal-title":"PLoS ONE"},{"key":"4578_CR53","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M et al (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013D361","journal-title":"Nucleic Acids Res"},{"key":"4578_CR54","doi-asserted-by":"publisher","first-page":"104847","DOI":"10.1016\/j.phrs.2020.104847","volume":"158","author":"KS Abdelwahed","year":"2020","unstructured":"Abdelwahed KS, Siddique AB, Mohyeldin MM et al (2020) Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor. Pharmacol Res 158:104847","journal-title":"Pharmacol Res"},{"key":"4578_CR55","doi-asserted-by":"publisher","first-page":"e64145","DOI":"10.1371\/journal.pone.0064145","volume":"8","author":"M Canuel","year":"2013","unstructured":"Canuel M, Sun X, Asselin M-C et al (2013) Proprotein convertase subtilisin\/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1). PLoS ONE 8:e64145","journal-title":"PLoS ONE"},{"key":"4578_CR56","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1093\/nar\/30.10.2172","volume":"30","author":"BC Godthelp","year":"2002","unstructured":"Godthelp BC, Wiegant WW, van Duijn-Goedhart A et al (2002) Mammalian Rad51C contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic Acids Res 30:2172\u20132182","journal-title":"Nucleic Acids Res"},{"key":"4578_CR57","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1158\/0008-5472.CAN-03-3608","volume":"64","author":"PP Connell","year":"2004","unstructured":"Connell PP, Siddiqui N, Hoffman S et al (2004) A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin. Cancer Res 64:3002\u20133005","journal-title":"Cancer Res"},{"key":"4578_CR58","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/nar\/30.4.1001","volume":"30","author":"C Wiese","year":"2002","unstructured":"Wiese C, Collins DW, Albala JS et al (2002) Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells. Nucleic Acids Res 30:1001\u20131008","journal-title":"Nucleic Acids Res"},{"key":"4578_CR59","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/nar\/30.4.1009","volume":"30","author":"N Liu","year":"2002","unstructured":"Liu N, Schild D, Thelen MP, Thompson LH (2002) Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res 30:1009\u20131015","journal-title":"Nucleic Acids Res"},{"key":"4578_CR60","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1478-811X-7-16","volume":"7","author":"I B\u00f6hme","year":"2009","unstructured":"B\u00f6hme I, Beck-Sickinger AG (2009) Illuminating the life of GPCRs. Cell Commun Signal 7:16","journal-title":"Cell Commun Signal"},{"key":"4578_CR61","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE et al (2013) Cancer genome landscapes. Science 339:1546\u20131558","journal-title":"Science"},{"key":"4578_CR62","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","volume":"14","author":"AS Baldwin","year":"1996","unstructured":"Baldwin AS (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649\u2013683","journal-title":"Annu Rev Immunol"},{"key":"4578_CR63","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00204-015-1470-4","volume":"89","author":"F Li","year":"2015","unstructured":"Li F, Zhang J, Arfuso F et al (2015) NF-\u03baB in cancer therapy. Arch Toxicol 89:711\u2013731","journal-title":"Arch Toxicol"},{"key":"4578_CR64","first-page":"675","volume":"24","author":"M Kojima","year":"2004","unstructured":"Kojima M, Morisaki T, Sasaki N et al (2004) Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res 24:675\u2013681","journal-title":"Anticancer Res"},{"key":"4578_CR65","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11010-018-3365-1","volume":"449","author":"B Liu","year":"2018","unstructured":"Liu B, Xu T, Xu X et al (2018) Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-\u03baB signal transduction. Mol Cell Biochem 449:285\u2013294","journal-title":"Mol Cell Biochem"},{"key":"4578_CR66","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0968-0004(03)00193-2","volume":"28","author":"MJ Cross","year":"2003","unstructured":"Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L (2003) VEGF-receptor signal transduction. Trends Biochem Sci 28:488\u2013494","journal-title":"Trends Biochem Sci"},{"key":"4578_CR67","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD et al (2017) The PI3K pathway in human disease. Cell 170:605\u2013635","journal-title":"Cell"},{"key":"4578_CR68","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semcancer.2019.04.001","volume":"59","author":"Q Yang","year":"2019","unstructured":"Yang Q, Jiang W, Hou P (2019) Emerging role of PI3K\/AKT in tumor-related epigenetic regulation. Semin Cancer Biol 59:112\u2013124","journal-title":"Semin Cancer Biol"},{"key":"4578_CR69","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/0008-5472.CAN-18-0668","volume":"79","author":"KS Bishnupuri","year":"2019","unstructured":"Bishnupuri KS, Alvarado DM, Khouri AN et al (2019) IDO1 and kynurenine pathway metabolites activate PI3K-Akt signaling in the neoplastic colon epithelium to promote cancer cell proliferation and inhibit apoptosis. Cancer Res 79:1138\u20131150","journal-title":"Cancer Res"},{"key":"4578_CR70","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/35074129","volume":"410","author":"L Johnson","year":"2001","unstructured":"Johnson L, Mercer K, Greenbaum D et al (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410:1111\u20131116","journal-title":"Nature"},{"key":"4578_CR71","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature12205","volume":"497","author":"G Zimmermann","year":"2013","unstructured":"Zimmermann G, Papke B, Ismail S et al (2013) Small molecule inhibition of the KRAS-PDE\u03b4 interaction impairs oncogenic KRAS signalling. Nature 497:638\u2013642","journal-title":"Nature"},{"key":"4578_CR72","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H et al (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic acids Res 42:D92\u2013D97","journal-title":"Nucleic acids Res"},{"key":"4578_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-017-0588-9","volume":"16","author":"YW Liu","year":"2017","unstructured":"Liu YW, Xia R, Lu K et al (2017) LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Mol Cancer 16:39","journal-title":"Mol Cancer"},{"key":"4578_CR74","doi-asserted-by":"publisher","first-page":"11271","DOI":"10.18632\/oncotarget.7168","volume":"7","author":"N Chen","year":"2016","unstructured":"Chen N, Guo D, Xu Q et al (2016) Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma. Oncotarget 7:11271\u201311283","journal-title":"Oncotarget"},{"key":"4578_CR75","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cca.2019.07.004","volume":"497","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Xu S, Xia H et al (2019) Long noncoding RNA FEZF1-AS1 in human cancers. Clin Chim Acta 497:20\u201326","journal-title":"Clin Chim Acta"},{"key":"4578_CR76","doi-asserted-by":"publisher","first-page":"839","DOI":"10.17219\/acem\/135693","volume":"30","author":"T Zhang","year":"2021","unstructured":"Zhang T, Yu S, Zhao S (2021) LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p\/PRRX1 pathway. Adv Clin Exp Med 30:839\u2013848","journal-title":"Adv Clin Exp Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04578-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T18:09:30Z","timestamp":1682359770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04578-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["4578"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04578-y","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Ethical approval to the human study was provided by Lanzhou University Second Hospital medical ethics committee (APPROVAL NUMBER 2021A-468).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained the informed consents\u00a0from the colon cancer patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}